JIANG Rong, CHEN Tong, SHAO Rong*

Corresponding author: Shao Rong, shaorong118@163.com

DOI: 10.12201/bmr.202007.00023

•  

  Abstract: Objective To analyze and compare the implementation methods of the Patient Assistance Programs in China and US, and to provide recommendations for promoting the development of Chinas charitable donations and improving medical security system. Methods Through literature research and a review of domestic and foreign patient assistance platforms, the implementation methods of the Patient Assistance Programs in China and US were summarized. And through comparison, the implementation differences between China and US were concluded. Results China’s Patient Assistance Programs are later than the US more than 30 years. Compared with US, there is a single implementation subject, simpler implementation methods, and a small number of covered drugs in China. Conclusion It is recommended that pharmaceutical companies innovate the assistance models of Patient Assistance Programs, and select drugs based on the disease needs of the patient group, and to promote the implementation of Patient Assistance Programs and improve medical security system in China.

  Key words: Drug; Patient Assistance Programs; Implementation Methods

  Submit time: 15 December 2020

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Li Hong-yu, Sun Qiang. Analysis of the impact of the Two Ballot System policy on drug supply in Shandong province. 2021. doi: 10.12201/bmr.202011.00015

  weixueyao, zhenghui, chenying, liuzhen, niruyang, liuyanting. DESIGN AND IMPLEMENTATION OF CLINICAL PATHWAY SYSTEM BASED ON SPECIFIC INDEX AND IMPLEMENTATION EFFECT EVALUATION. 2020. doi: 10.12201/bmr.202010.00839

  caohaixia, 刘宇薇. Comparative Study on Public Health Information Services of Libraries at Home and Abroad. 2020. doi: 10.12201/bmr.201908.00001

  HU Guang-yu, TAO Chenglin, Zeng De-wei, Lin De-nan. Measure of specialty case-mix index based on standardization of patient groups distribution. 2020. doi: 10.12201/bmr.202005.00251

  JIA Yan-bing, SHI Zhen-yu, YUAN Bei-bei, XU Jin, MENG Qing-yue, HE ping. Analysis on the status quo of research project and funding in health policy and systems research in China. 2020. doi: 10.12201/bmr.202006.00010

  Establishing a symptom management system based on electronic patient-reported outcome. 2020. doi: 10.12201/bmr.202004.00023

  Zhang Xiaoxing, Zhou Tingting, PAN JAY. Implications on the Model of Drug Guarantee for Rare Diseases at Domestic and Abroad. 2020. doi: 10.12201/bmr.202009.00016

  Luxinyi, Wangyadong. The construction of the comprehensive regulation system of the medical and health industry :a qualitative analysis based on the grounded theory. 2021. doi: 10.12201/bmr.201910.00001

  Zhu Xiaoxiao, Qian Aibing. Analysis of Network Attention Characteristics of Breast Cancer Prevention and Treatment Health Information Based on Baidu Index. 2020. doi: 10.12201/bmr.201906.00001

  CHUZhenYu, ZHENGJing, HOUHu, GAODongPing, YUANKeHong. Patient information sharing platform to promote inter-accreditation of medical lab test.. 2020. doi: 10.12201/bmr.202008.00020

• ID	Submit time	Number	Download
  1	2020-07-31	bmr.202007.00023V1	Download

• Public  Anonymous  To author only Submit Comments